T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jaci.2017.11.050
PubMed Identifier: 29355678
Publication URI: http://europepmc.org/abstract/MED/29355678
Type: Journal Article/Review
Volume: 142
Parent Publication: The Journal of allergy and clinical immunology
Issue: 3
ISSN: 0091-6749